DADI | FIRST NEWSLETTER

August 4, 2022

The 1st DADI newsletter has been published on the EMA website!

The digital application dataset integration (DADI) newsletter is published four times a year and provides pharmaceutical companies and the national competent authorities in the EU updates on the progress of the DADI project.

This first issue covers topics such as:

• DADI and PMS overview
• Updated roadmap for DADI as the scope of the October 2022 Go-live will be limited to CAPs
• User Acceptance Testing (UAT) for Human Variations Form with a selected group of testers to be conducted between 5 September and 16 September 2022

Additionally, we would like to remind you that the next DADI and Q&A public webinar will be held on Friday, 2 September 2022 (Link to registration)

You can find the complete first issue of the newsletter here.

Search News & Events

  • Filter by category

Share

Related news and events

NEW | User Acceptance Testing (UAT) phase

Asphalion Expert Beatriz Ugalde Dionicio has been selected by the European Medicines Agency (EMA) to participate in the Product Management Service (PMS) Product User Interface

EVENT | 4YFN

From 26 to 29 of February Asphalion will be the 4YFN within the Mobile World Congress in Barcelona!   Asphalion experts will be happy to receive

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting